Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo-Reference-Cited by-同舟云学术

Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo

Published:2022-07-27 Issue:27 Volume:9 Page:2201294
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Kayabolen Alisan¹^ORCID,Akcan Ugur¹^ORCID,Özturan Doğancan¹^ORCID,Ulbegi‐Polat Hivda²^ORCID,Sahin Gizem Nur¹^ORCID,Pinarbasi‐Degirmenci Nareg¹^ORCID,Bayraktar Canan¹^ORCID,Soyler Gizem¹^ORCID,Sarayloo Ehsan¹³^ORCID,Nurtop Elif⁴^ORCID,Ozer Berna⁴^ORCID,Guney‐Esken Gulen⁴^ORCID,Barlas Tayfun⁴^ORCID,Yildirim Ismail Selim²,Dogan Ozlem⁴⁵^ORCID,Karahuseyinoglu Sercin¹⁶^ORCID,Lack Nathan A.¹⁷^ORCID,Kaya Mehmet¹,Albayrak Cem¹³^ORCID,Can Fusun⁴⁵^ORCID,Solaroglu Ihsan¹⁸^ORCID,Bagci‐Onder Tugba¹^ORCID

Affiliation:

1. Koç University Research Center for Translational Medicine (KUTTAM) Koç University Istanbul 34450 Turkey

2. Genetic Engineering and Biotechnology Institute TUBITAK Marmara Research Center Kocaeli 41470 Turkey

3. Department of Biotechnology Beykoz Institute of Life Sciences and Biotechnology (BILSAB) Bezmialem Vakif University Istanbul 34820 Turkey

4. Koç University Isbank Center for Infectious Diseases (KUISCID) Istanbul 34010 Turkey

5. Koç University School of Medicine Department of Medical Microbiology Istanbul 34010 Turkey

6. Koç University School of Medicine, Department of Histology and Embryology Istanbul 34450 Türkiye

7. Vancouver Prostate Centre University of British Columbia Vancouver BC V6H 3Z6 Canada

8. Department of Basic Sciences Loma Linda University Loma Linda CA 92354 USA

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202201294

Reference86 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. WHO. WHO Director‐General's opening remarks at the media briefing on COVID‐19 –11 March 2020 https://www.who.int/director‐general/speeches/detail/who‐director‐general‐s‐opening‐remarks‐at‐the‐media‐briefing‐on‐covid‐19‐11‐march‐2020(accessed: December 2020).

4. W. H. O. W. H. O. Coronavirus (COVID‐19) Dashboard https://covid19.who.int/(accessed: March 2022).

5. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining poly-epitope MoonTags and labeled nanobodies for signal amplification in cell-specific PET imaging in vivo;Nuclear Medicine and Biology;2024-09

2. Antiviral effect of cannabidiol on K18‐hACE2 transgenic mice infected with SARS‐CoV‐2;Journal of Cellular and Molecular Medicine;2024-09

3. ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection;International Journal of Nanomedicine;2024-07

4. Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production;Scientific Reports;2024-06-15

5. ACE2 Receptor: A Potential Pharmacological Target in COVID-19;Current Protein & Peptide Science;2023-11